Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shariq Haider

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 15, 2015
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveMichel Laverdiere, Eric J Bow, Coleman Rotstein, et al.
Clinical Drug Investigation|September 7, 2023
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive AspergillosisJohan A Maertens, Galia Rahav, Dong-Gun Lee, et al.
Cancers|January 10, 2026
Human Papillomavirus Self-Sampling Attitudes Amongst Women Living with HIV Prior to a Self-Sampling InterventionSofia Nicolls, Emma Karlsen, Isabelle Boucoiran, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2015
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal diseaseOliver A Cornely, Rafael F Duarte, Shariq Haider, et al.
Antibodies (Basel, Switzerland)|April 27, 2026
SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIVSharon L Walmsley, Leif Erik Lovblom, Bryan Boyachuk, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2016
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal diseaseOliver A Cornely, Rafael F Duarte, Shariq Haider, et al.
The Journal of Infectious Diseases|September 20, 2024
Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus InfectionSunwen Chou, Drew J Winston, Robin K Avery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropeniaRafael F Duarte, Javier López-Jiménez, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
AURORA: A New DawnGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 15, 2015
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveMichel Laverdiere, Eric J Bow, Coleman Rotstein, et al.
Clinical Drug Investigation|September 7, 2023
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive AspergillosisJohan A Maertens, Galia Rahav, Dong-Gun Lee, et al.
Cancers|January 10, 2026
Human Papillomavirus Self-Sampling Attitudes Amongst Women Living with HIV Prior to a Self-Sampling InterventionSofia Nicolls, Emma Karlsen, Isabelle Boucoiran, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2015
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal diseaseOliver A Cornely, Rafael F Duarte, Shariq Haider, et al.
Antibodies (Basel, Switzerland)|April 27, 2026
SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIVSharon L Walmsley, Leif Erik Lovblom, Bryan Boyachuk, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2016
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal diseaseOliver A Cornely, Rafael F Duarte, Shariq Haider, et al.
The Journal of Infectious Diseases|September 20, 2024
Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus InfectionSunwen Chou, Drew J Winston, Robin K Avery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropeniaRafael F Duarte, Javier López-Jiménez, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
AURORA: A New DawnGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Pageof 6